ym 872 has been researched along with Brain Ischemia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anraku, T; Asano, J; Hori, W; Shiga, F; Takano, Y; Uno, T | 1 |
| Kawasaki-Yatsugi, S; Kohara, A; Ni, JW; Okada, M; Sakamoto, S; Shimizu-Sasamata, M; Shishikura, J; Takahashi, M; Yamaguchi, T; Yatsugi, S | 1 |
| Kawasaki-Yatsugi, S; Koshiya, K; Ni, JW; Sakamoto, S; Shimizu-Sasamata, M; Shishikura, JI; Takahashi, M; Toya, T; Yamaguchi, T; Yatsugi, SI | 1 |
| Ichiki, C; Kawasaki-Yatsugi, S; Minematsu, K; Shimizu-Sasamata, M; Takahashi, M; Toya, T; Yamaguchi, T; Yatsugi, S | 1 |
| Kano, T; Lo, EH; Moskowitz, MA; Rogowska, J; Shimizu-Sasamata, M; Wolf, GL | 1 |
| Ichiki, C; Kawasaki-Yatsugi, S; Koshiya, K; Ni, JW; Shimizu-Sasamata, M; Takahashi, M; Toya, T; Yamaguchi, T; Yatsugi, SI | 1 |
| Ni, JW; Shimizu-Sasamata, M; Takahashi, M; Yamaguchi, T; Yatsugi, S | 1 |
| Ichiki, C; Kawasaki-Yatsugi, S; Minematsu, K; Shimizu-Sasamata, M; Takahashi, M; Yamaguchi, T; Yatsugi, S | 1 |
| Lo, EH; Moskowitz, MA; Sasamata, M | 1 |
2 review(s) available for ym 872 and Brain Ischemia
| Article | Year |
|---|---|
YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.
Topics: Animals; Brain Ischemia; Cats; Clinical Trials, Phase I as Topic; Disease Models, Animal; Excitatory Amino Acid Antagonists; Humans; Imidazoles; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Quinoxalines; Rats; Receptors, AMPA; Solubility; Stroke | 2002 |
[New method for evaluating the effects of neuroprotective therapy in the hemodynamic penumbra].
Topics: Animals; Brain Ischemia; Endothelium, Vascular; Hemodynamics; Imidazoles; Mice; Mice, Knockout; Neuroprotective Agents; Nitric Oxide Synthase; Quinoxalines; Rats; Receptors, AMPA; Tomography, X-Ray Computed | 2000 |
7 other study(ies) available for ym 872 and Brain Ischemia
| Article | Year |
|---|---|
Synthesis and AMPA receptor antagonistic activity of a novel 7-imidazolyl-6-trifluoromethyl quinoxalinecarboxylic acid with a substituted phenyl group and improved its good physicochemical properties by introduced CF3 group.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Imidazoles; In Vitro Techniques; Infusions, Intravenous; Neuroprotective Agents; Quinoxalines; Rats; Receptors, AMPA; Solubility; Structure-Activity Relationship | 2004 |
YM872, a novel selective alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.
Topics: Animals; Brain; Brain Ischemia; Cats; Cerebral Cortex; Corpus Striatum; Imidazoles; Male; Neuroprotective Agents; Quinoxalines; Receptors, AMPA; Regional Blood Flow | 1998 |
A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.
Topics: Animals; Arterial Occlusive Diseases; Blood Gas Analysis; Body Temperature; Brain; Brain Ischemia; Cerebral Arteries; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Infusions, Intravenous; Kidney; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Time Factors | 1998 |
YM872, a highly water-soluble AMPA receptor antagonist, preserves the hemodynamic penumbra and reduces brain injury after permanent focal ischemia in rats.
Topics: Animals; Brain; Brain Ischemia; Cerebrovascular Circulation; Hemodynamics; Imidazoles; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred F344; Receptors, AMPA; Solubility; Time Factors; Tomography, X-Ray Computed; Water | 1998 |
Neuroprotective efficacy of YM872, an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in rats.
Topics: Animals; Brain Ischemia; Cerebral Arteries; Excitatory Amino Acid Antagonists; Imidazoles; Male; Motor Activity; Quinoxalines; Rats; Rats, Inbred F344; Receptors, AMPA | 1998 |
Effects of YM872 on atrophy of substantia nigra reticulata after focal ischemia in rats.
Topics: Animals; Arterial Occlusive Diseases; Atrophy; Body Temperature; Body Weight; Brain Ischemia; Cerebral Infarction; Imidazoles; Male; Neurologic Examination; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred F344; Receptors, AMPA; Substantia Nigra | 1998 |
Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model.
Topics: Animals; Brain Ischemia; Cerebral Arteries; Cerebrovascular Disorders; Imidazoles; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Reperfusion Injury | 2000 |